Abellanosa, Christina B.

HRN: 27-55-81  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2025
CEFUROXIME 750MG (VIAL)
09/07/2025
09/14/2025
IV
750mg
Q8
Lumpectomy
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: Compliant To Guidelines